DIETARY SUPPLEMENT CONSIDERATIONS DURING GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST TREATMENT: A NARRATIVE REVIEW

Descargar Publicación
CRF1 and ACTH inhibitors are a promising approach to treat obesity and leptin and insulin resistance Linking Metabolic Disorders and Immune System Phenomena in Schizophrenia: The Role of Adipose Tissue and Inflammation